[go: up one dir, main page]

CN118203116A - A method for maintaining probiotic activity and active protection composition - Google Patents

A method for maintaining probiotic activity and active protection composition Download PDF

Info

Publication number
CN118203116A
CN118203116A CN202410415297.1A CN202410415297A CN118203116A CN 118203116 A CN118203116 A CN 118203116A CN 202410415297 A CN202410415297 A CN 202410415297A CN 118203116 A CN118203116 A CN 118203116A
Authority
CN
China
Prior art keywords
powder
probiotic
sodium citrate
active
milk powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202410415297.1A
Other languages
Chinese (zh)
Inventor
董权锋
王婧
迮晓雷
奚彧
赵溪
郭佳欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BY Health Co Ltd
Original Assignee
BY Health Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BY Health Co Ltd filed Critical BY Health Co Ltd
Priority to CN202410415297.1A priority Critical patent/CN118203116A/en
Publication of CN118203116A publication Critical patent/CN118203116A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/70Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729Organic compounds; Microorganisms; Enzymes
    • A23B2/733Compounds of undetermined constitution obtained from animals or plants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/70Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729Organic compounds; Microorganisms; Enzymes
    • A23B2/742Organic compounds containing oxygen
    • A23B2/754Organic compounds containing oxygen containing carboxyl groups
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/37Sugar alcohols
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to the technical field of microorganisms, in particular to a method for maintaining the activity of probiotics and an activity protection composition. The method comprises adding an active protective composition to a probiotic powder; the active protection composition comprises milk powder and sodium citrate, wherein the mass ratio of the milk powder to the sodium citrate is 10-25:1. The acid and alkali salt resistance of the probiotics can be effectively improved by adding the active protective composition comprising whole milk or skim milk powder and sodium citrate into the probiotics; the further active protection method and the active protection composition can ensure that the microbial probiotics in the prepared probiotic powder keep low water activity by matching with the granulation process, maintain high viable bacteria number and have good powder bagging process compliance.

Description

一种维持益生菌活性的方法及活性保护组合物A method for maintaining the activity of probiotics and an activity protection composition

技术领域Technical Field

本发明涉及微生物技术领域,具体涉及一种维持益生菌活性的方法及活性保护组合物。The present invention relates to the field of microbial technology, and in particular to a method for maintaining the activity of probiotics and an activity protection composition.

背景技术Background technique

2001年世界卫生组织和联合国粮农组织共同对“益生菌”作出定义,摄取适当数量时,可对宿主健康发挥有益作用的活菌称为益生菌。近年来科学研究表明,益生菌在宿主肠道定植,通过改善肠道微生态平衡发挥有利于宿主的作用,例如调节宿主免疫,改善宿主代谢。相关研究成果为益生菌在生物医药领域带来广阔应用前景,近年来全球多个益生菌药物已经处于临床研究中。在益生菌制品中,“活的菌株”与“足够数量”是益生菌的两大核心,然而,作为微生物的益生菌十分脆弱,易受到环境因素的影响,目前很多益生菌制品在生产、加工以及环境存储过程中大量的益生菌死亡,活菌数较低;同时,存活的益生菌到达人体肠道中,需要经过多个生物屏障,益生菌对胃肠道的耐受力和黏附能力是其发挥生理功效的必要条件。在人体众多防御机制中,胃液提供的强酸环境、以及肠液提供的高胆盐环境对微生物的活性影响最大。细菌从口腔进入消化道后,胃部和小肠环境含有的胃酸、胆盐、消化酶、电解质等会影响微生物的活性,影响生物膜的组成,改变生物膜的流动性,影响微生物对营养物质的吸收和代谢产物的排出,对微生物造成破坏甚至灭活作用。In 2001, the World Health Organization and the Food and Agriculture Organization of the United Nations jointly defined "probiotics". When ingested in appropriate quantities, live bacteria that can play a beneficial role in the health of the host are called probiotics. In recent years, scientific research has shown that probiotics colonize the host's intestines and play a beneficial role in the host by improving the balance of intestinal microecology, such as regulating host immunity and improving host metabolism. Related research results have brought broad application prospects for probiotics in the field of biomedicine. In recent years, many probiotic drugs around the world have been in clinical research. In probiotic products, "live strains" and "sufficient numbers" are the two core elements of probiotics. However, as microorganisms, probiotics are very fragile and easily affected by environmental factors. At present, many probiotic products die in large numbers during production, processing and environmental storage, and the number of live bacteria is low. At the same time, surviving probiotics need to pass through multiple biological barriers to reach the human intestine. The tolerance and adhesion ability of probiotics to the gastrointestinal tract are necessary conditions for them to exert their physiological effects. Among the many defense mechanisms of the human body, the strong acid environment provided by gastric juice and the high bile salt environment provided by intestinal juice have the greatest impact on the activity of microorganisms. After bacteria enter the digestive tract from the mouth, the gastric acid, bile salts, digestive enzymes, electrolytes, etc. contained in the stomach and small intestine environment will affect the activity of microorganisms, affect the composition of the biofilm, change the fluidity of the biofilm, affect the microorganism's absorption of nutrients and the excretion of metabolic products, and cause damage to or even inactivate the microorganisms.

粉剂,凭借其袋包工艺成熟、消费者接受程度高、可广泛应用于普通食品和保健食品销售等优势,一直以来作为市面上益生菌产品的主要剂型被广泛地开发应用。益生菌粉剂是以一种以批准的活性微生物,经发酵、富集、乳化或不乳化、干燥或不干燥、添加或不添加辅料、混合或不混合、包装等工序制成的菌剂。目前,如何维持以益生菌粉剂为代表的益生菌相关产品中的活菌数量已经成为行业研发及创新过程关注的方向之一。Powders, with their mature bag-packing technology, high consumer acceptance, and wide application in the sales of ordinary foods and health foods, have been widely developed and applied as the main dosage form of probiotic products on the market. Probiotic powders are a kind of bacterial agent made from approved active microorganisms through fermentation, enrichment, emulsification or non-emulsification, drying or non-drying, addition or non-addition of excipients, mixing or non-mixing, packaging and other processes. At present, how to maintain the number of live bacteria in probiotic-related products represented by probiotic powders has become one of the focuses of the industry's research and development and innovation process.

中国发明专利申请CN108813450A公开了一种改善肠道微生物的粉剂组合物及制备方法,含有膳食纤维、蔬菜类组合物、水果类组合物和益生元,每100g含:膳食纤维20-60%;蔬菜类组合物15-40%;水果类组合物10-50%;益生元50-85亿CFU。该改善肠道微生物的粉剂组合物及制备方法可以快速补充更有效的益生菌活力组合含有源于肠道内的乳酸菌、双歧杆菌,以及为在肠道内繁殖创造环境的芽孢杆菌,使人体的肠胃处于一个良性健康的环境。Chinese invention patent application CN108813450A discloses a powder composition for improving intestinal microorganisms and a preparation method thereof, which contains dietary fiber, vegetable composition, fruit composition and prebiotics, and each 100g contains: 20-60% dietary fiber; 15-40% vegetable composition; 10-50% fruit composition; 5.0-8.5 billion CFU of prebiotics. The powder composition for improving intestinal microorganisms and the preparation method thereof can quickly supplement the more effective probiotic vitality combination containing lactic acid bacteria and bifidobacteria from the intestines, and bacillus that creates an environment for reproduction in the intestines, so that the human stomach and intestines are in a benign and healthy environment.

中国发明专利申请CN111066888A公开了一种益生菌粉剂,按照质量份数包括以下组分:益生菌粉5-10份、益生菌保护剂300-350份、甜味剂20-30份,益生菌粉包括植物乳杆菌、两歧双歧杆菌、及干酪乳杆菌,且益生菌粉的总菌含量大于160亿cfu/g,其中干酪乳杆菌占益生菌粉总重的55%-65%。益生菌保护剂包括脱脂乳、菊粉、海藻糖、麦芽糊精及谷物纤维粉,其中脱脂乳占益生菌保护剂总重的50%-60%,谷物纤维粉占益生菌保护剂总重的20%-30%。该发明能够有效调节肠道菌群,促进益生菌在肠道内生长,保证益生菌在肠道中的活菌量。益生菌保护剂对益生菌粉起到保护作用,尤其是谷物纤维与脱脂乳相配合,能在胃酸胆汁等极端环境下降低益生菌损耗,提高其到达肠道时的活菌量。Chinese invention patent application CN111066888A discloses a probiotic powder, which includes the following components by mass: 5-10 parts of probiotic powder, 300-350 parts of probiotic protective agent, and 20-30 parts of sweetener. The probiotic powder includes plant lactobacillus, bifidobacterium bifidum, and lactobacillus casei, and the total bacterial content of the probiotic powder is greater than 16 billion cfu/g, wherein lactobacillus casei accounts for 55%-65% of the total weight of the probiotic powder. The probiotic protective agent includes skim milk, inulin, trehalose, maltodextrin and cereal fiber powder, wherein skim milk accounts for 50%-60% of the total weight of the probiotic protective agent, and cereal fiber powder accounts for 20%-30% of the total weight of the probiotic protective agent. The invention can effectively regulate intestinal flora, promote the growth of probiotics in the intestine, and ensure the amount of live probiotics in the intestine. Probiotic protective agents play a protective role on probiotic powder, especially the combination of cereal fiber and skim milk, which can reduce the loss of probiotics in extreme environments such as gastric acid and bile, and increase the amount of live bacteria when they reach the intestines.

益生菌类产品在工业生产后,在长久的货架期中氧气、水分等因素,会对益生菌的菌活造成严重影响。另外,在进食后,短时间内由于胃内容物的增加,胃液pH值会升高至3-4左右,且肝脏分泌的胆盐随着胆汁大量进入小肠,胃肠道的低pH、高胆盐环境也会对益生菌的菌活造成严重影响。因此菌株能否抵御货架期各种环境因素、以及体内低pH、高胆盐的复杂环境,顺利到达肠道存活、繁殖并具有代谢活性,是检验产品质量的关键指标之一。After industrial production, factors such as oxygen and moisture will have a serious impact on the activity of probiotics during the long shelf life. In addition, after eating, due to the increase in stomach contents, the pH value of gastric juice will rise to about 3-4 in a short period of time, and the bile salts secreted by the liver will enter the small intestine in large quantities along with the bile. The low pH and high bile salt environment of the gastrointestinal tract will also have a serious impact on the activity of probiotics. Therefore, whether the strain can resist various environmental factors during the shelf life, as well as the complex environment of low pH and high bile salts in the body, and successfully reach the intestine to survive, reproduce and have metabolic activity, is one of the key indicators for testing product quality.

现有技术中,大量益生菌相关产品并未有效考虑到货架期的各种环境因素,以及产品摄食后经过下消化道(尤其受到胃液、胆盐和肠液等影响因素)的存活情况,严重影响了益生菌粉剂的实际效果及质量。个别的现有技术提到了益生菌保护剂,但未充分考虑各种影响因素,且存在保护剂体系构成复杂,且保护效果未经过科学验证的问题。以CN111066888A为例,其保护剂由脱脂乳、菊粉、海藻糖、麦芽糊精及谷物纤维粉组成,该保护剂组成复杂,且保护效果未经科学验证,影响了体系在益生菌类产品中的适用性。由此可见,现有技术缺少适用性广、保护效果好的益生菌保护试剂及其产品配方。In the prior art, a large number of probiotic-related products have not effectively considered various environmental factors of the shelf life, as well as the survival of the product after ingestion through the lower digestive tract (especially affected by factors such as gastric juice, bile salts and intestinal juice), which seriously affects the actual effect and quality of the probiotic powder. Some prior art mentions probiotic protective agents, but does not fully consider various influencing factors, and there are problems such as the complex composition of the protective agent system and the protection effect has not been scientifically verified. Taking CN111066888A as an example, its protective agent is composed of skim milk, inulin, trehalose, maltodextrin and cereal fiber powder. The protective agent is complex in composition, and the protection effect has not been scientifically verified, which affects the applicability of the system in probiotic products. It can be seen that the prior art lacks probiotic protective agents and product formulas with wide applicability and good protection effect.

如何开发一种适应性广、保护效果好的益生菌活性保护方法、提供一种活性保护组合物满足显著提高活菌通过人体下消化道存活率的要求,而且能有效提高产品货架期内活菌的稳定性是本领域亟待解决的技术问题。How to develop a method for protecting the active probiotics with wide adaptability and good protection effect, and provide an active protection composition that can significantly improve the survival rate of live bacteria through the lower digestive tract of the human body, and effectively improve the stability of live bacteria during the shelf life of the product is a technical problem that needs to be urgently solved in this field.

发明内容Summary of the invention

本发明通过广泛的研究,意外的发现了一种简易有效维持益生菌活性的方法及活性保护组合物,该组合物不仅能显著提高活菌通过人体下消化道存活率,而且能有效提高产品货架期内活菌的稳定性。Through extensive research, the present invention unexpectedly discovered a simple and effective method for maintaining the activity of probiotics and an activity protection composition, which can not only significantly improve the survival rate of live bacteria through the lower digestive tract of the human body, but also effectively improve the stability of live bacteria during the shelf life of the product.

本发明是通过以下技术方案实现:The present invention is achieved through the following technical solutions:

本发明的第一个方面提供一种维持益生菌活性的方法,所述方法包括在益生菌粉中添加活性保护组合物;所述活性保护组合物包括乳粉和柠檬酸钠,所述乳粉和柠檬酸钠的质量比为10-25:1。The first aspect of the present invention provides a method for maintaining the activity of probiotics, the method comprising adding an activity protection composition to probiotic powder; the activity protection composition comprises milk powder and sodium citrate, and the mass ratio of the milk powder to the sodium citrate is 10-25:1.

优选地,所述活性保护组合物由所述乳粉和柠檬酸钠混合、造粒、过筛制得;所述过筛具体为:活性保护组合物过180-220目筛,筛下物含量小于总量的60%,过35-45目筛,筛下物含量大于总量的90%,过10-20目筛,筛下物含量等于100%。Preferably, the active protective composition is prepared by mixing, granulating and sieving the milk powder and sodium citrate; the sieving specifically comprises: the active protective composition is sieved through a 180-220 mesh sieve, the content of the sieve under material is less than 60% of the total amount, the sieve under material is sieved through a 35-45 mesh sieve, the content of the sieve under material is greater than 90% of the total amount, and the sieve under material is sieved through a 10-20 mesh sieve, the content of the sieve under material is equal to 100%.

本发明的第二个方面提供一种维持益生菌活性的活性保护组合物,所述活性保护组合物包括乳粉和柠檬酸钠,所述乳粉和柠檬酸钠的质量比为10-25:1。The second aspect of the present invention provides an active protective composition for maintaining the activity of probiotics, wherein the active protective composition comprises milk powder and sodium citrate, wherein the mass ratio of the milk powder to the sodium citrate is 10-25:1.

优选地,所述乳粉和柠檬酸钠的质量比为15-25:1。Preferably, the mass ratio of the milk powder to sodium citrate is 15-25:1.

优选地,所述活性保护组合物还包括填充剂,所述填充剂:乳粉:柠檬酸钠的质量比为150-180:15-25:1。Preferably, the active protective composition further comprises a filler, and the mass ratio of the filler: milk powder: sodium citrate is 150-180:15-25:1.

进一步优选地,所述填充剂选自膳食纤维、糖醇、低聚糖和果汁粉中的至少一种,其中所述膳食纤维选自抗性糊精和麦芽糊精中的至少一种,所述糖醇选自赤藓糖醇和麦芽糖醇中的至少一种,所述低聚糖选自低聚果糖和低聚半乳糖中的至少一种。Further preferably, the filler is selected from at least one of dietary fiber, sugar alcohol, oligosaccharides and fruit juice powder, wherein the dietary fiber is selected from at least one of resistant dextrin and maltodextrin, the sugar alcohol is selected from at least one of erythritol and maltitol, and the oligosaccharides are selected from at least one of fructo-oligosaccharides and galacto-oligosaccharides.

进一步优选地,所述填充剂包括抗性糊精、赤藓糖醇和麦芽糖醇,所述抗性糊精、赤藓糖醇和麦芽糖醇的质量比为3-5:2-3:2-3。Further preferably, the filler comprises resistant dextrin, erythritol and maltitol, and the mass ratio of the resistant dextrin, erythritol and maltitol is 3-5:2-3:2-3.

优选地,所述活性保护组合物通过以下步骤制备得到:Preferably, the active protective composition is prepared by the following steps:

(1)将填充剂、全脂或脱脂乳粉和柠檬酸钠,混合,得到混合物A;(1) mixing a filler, whole milk powder or skim milk powder, and sodium citrate to obtain a mixture A;

(2)将混合物A置于造粒机中造粒,并烘干至水分<0.5%,水分活度<0.1,过筛,得到所述活性保护组合物。(2) The mixture A is placed in a granulator for granulation, and dried to a moisture content of less than 0.5% and a water activity of less than 0.1, and sieved to obtain the active protective composition.

进一步优选地,所述步骤(2)中过筛的标准为:过180-220目筛,筛下物含量小于总量的60%,过35-45目筛,筛下物含量大于总量的90%,过10-20目,筛下物含量等于100%。Further preferably, the sieving standard in step (2) is: after passing through a 180-220 mesh sieve, the content of the sieve undersize is less than 60% of the total amount; after passing through a 35-45 mesh sieve, the content of the sieve undersize is greater than 90% of the total amount; after passing through a 10-20 mesh sieve, the content of the sieve undersize is equal to 100%.

进一步优选地,所述步骤(2)中过筛的标准为:过200目筛,筛下物含量小于总量的60%,过40目筛,筛下物含量大于总量的90%,过10目,筛下物含量等于100%。Further preferably, the sieving standard in step (2) is: after passing through a 200-mesh sieve, the content of the sieve undersize is less than 60% of the total amount; after passing through a 40-mesh sieve, the content of the sieve undersize is greater than 90% of the total amount; after passing through a 10-mesh sieve, the content of the sieve undersize is equal to 100%.

本发明的第三个方面在于提供一种包括上述活性保护组合物的高活性益生菌粉剂。The third aspect of the present invention is to provide a high-activity probiotic powder comprising the above-mentioned active protection composition.

优选地,所述益生菌粉剂中益生菌粉与活性保护组合物的质量比为80-100:1-15。Preferably, the mass ratio of the probiotic powder to the active protection composition in the probiotic powder is 80-100:1-15.

优选地,所述益生菌选自双歧杆菌属,乳杆菌属,乳酪杆菌属,粘液乳杆菌属,乳植杆菌属,联合乳杆菌属,广布乳杆菌属,链球菌属,乳球菌属,丙酸杆菌属,丙酸菌属,明串珠菌属,片球菌属,魏茨曼氏菌属,动物球菌属,葡萄球菌属,或其任意组合。Preferably, the probiotic is selected from the group consisting of Bifidobacterium, Lactobacillus, Lactobacillus casei, Lactobacillus mucosus, Lactobacillus plantarum, Lactobacillus unisomeris, Lactobacillus spp., Streptococcus, Lactococcus, Propionibacterium, Propionibacterium, Leuconostoc, Pediococcus, Weizmannella, Zoococcus, Staphylococcus, or any combination thereof.

在某些实施方案中,所述双歧杆菌属的益生菌选自:青春双歧杆菌(Bifidobacterium adolescentis),动物双歧杆菌动物亚种(Bifidobacterium animalissubsp.animalis),动物双歧杆菌乳亚种(Bifidobacterium animalis subsp.lactis),两歧双歧杆菌(Bifidobacterium bifidum),短双歧杆菌(Bifidobacterium breve),长双歧杆菌婴儿亚种(Bifidobacterium longum subsp.infantis),长双歧杆菌长亚种(Bifidobacterium longum subsp.longum),或其任何组合。In certain embodiments, the probiotic of the genus Bifidobacterium is selected from the group consisting of Bifidobacterium adolescentis, Bifidobacterium animalis subsp. animalis, Bifidobacterium animalis subsp. lactis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum subsp. infantis, Bifidobacterium longum subsp. longum, or any combination thereof.

在某些实施方案中,所述乳杆菌属的益生菌选自:嗜酸乳杆菌(Lactobacillusacidophilus),卷曲乳杆菌(Lactobacillus crispatus),德氏乳杆菌保加利亚亚种(Lactobacillus delbrueckii subsp.bulgaricus),德氏乳杆菌乳亚种(Lactobacillusdelbrueckii subsp.lactis),格氏乳杆菌(Lactobacillus gasseri),瑞士乳杆菌(Lactobacillus helveticus),约氏乳杆菌(Lactobacillus johnsonii),马乳酒样乳杆菌马乳酒样亚种(Lactobacilus kefiranofaciens subsp.Kefiranofaciens),或其任何组合。In certain embodiments, the probiotic of the genus Lactobacillus is selected from: Lactobacillus acidophilus, Lactobacillus crispatus, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus delbrueckii subsp. lactis, Lactobacillus gasseri, Lactobacillus helveticus, Lactobacillus johnsonii, Lactobacilus kefiranofaciens subsp. Kefiranofaciens, or any combination thereof.

在某些实施方案中,所述乳酪杆菌属的益生菌选自:干酪乳杆菌(Lactobacilluscasei),短乳杆菌(Lactobacillus brevis),副干酪乳杆菌(Lactobacillus paracasei),鼠李糖乳酪杆菌(Lactobacillus rhamnosus),或其任何组合。In certain embodiments, the probiotic bacteria of the genus Lactobacillus are selected from the group consisting of Lactobacillus casei, Lactobacillus brevis, Lactobacillus paracasei, Lactobacillus rhamnosus, or any combination thereof.

在某些实施方案中,所述粘液乳杆菌属的益生菌选自:发酵粘液乳杆菌(Limosilactobacillus fermentum),罗伊氏粘液乳杆菌(Limosilactobacillusreuteri),或其组合。In certain embodiments, the probiotic bacteria of the genus Lactobacillus are selected from: Limosilactobacillus fermentum, Limosilactobacillus reuteri, or a combination thereof.

在某些实施方案中,所述乳植杆菌属的益生菌为植物乳植杆菌(Lactobacillusplantarum)。In certain embodiments, the probiotic of the genus Lactobacillus is Lactobacillus plantarum.

在某些实施方案中,所述联合乳杆菌属的益生菌为唾液联合乳杆菌(Ligilactobacillus salivarius)。In certain embodiments, the probiotic of the genus Lactobacillus is Ligilactobacillus salivarius.

在某些实施方案中,所述链球菌属的益生菌为唾液链球菌嗜热亚种(Streptococcus salivarius subsp.thermophilus)。In certain embodiments, the probiotic Streptococcus is Streptococcus salivarius subsp. thermophilus.

在某些实施方案中,所述丙酸杆菌属的益生菌为费氏丙酸杆菌谢氏亚种(Propionibacterium freudenreichii subsp.shermanii)。In certain embodiments, the probiotic bacteria of the genus Propionibacterium is Propionibacterium freudenreichii subsp. shermanii.

在某些实施方案中,所述丙酸菌属的益生菌为产丙酸丙酸菌(Propionibacteriumacidipropionici)。In certain embodiments, the probiotic bacteria of the genus Propionibacterium is Propionibacterium acidipropionici.

在某些实施方案中,所述乳球菌属的益生菌选自:乳酸乳球菌乳亚种(Lactococcus lactis subsp.Lactis),乳酸乳球菌乳亚种(双乙酰型)(Lactococcuslactis subsp.Lactis biovar diacetylactis),乳脂乳球菌(Lactococcus cermoris),或其任意组合。In certain embodiments, the probiotic bacteria of the genus Lactococcus are selected from: Lactococcus lactis subsp. Lactis, Lactococcus lactis subsp. Lactis biovar diacetylactis, Lactococcus cermoris, or any combination thereof.

与现有技术相比,本发明具有如下有益效果:(1)本发明将全脂或脱脂乳粉和柠檬酸钠通过比例组合使用,并将组合物的粒径通过造粒工艺控制在一定范围内,制备得到的活性保护组合物能有效保证水分活度,并具有良好的粉剂袋包工艺顺应性,同时能显著提高活菌通过人体下消化道的存活率;(2)本发明制备得到的活性保护组合物搭配益生菌以及其它食品用成分进行生产得到的益生菌粉剂产品,其水分活度数值小于0.15,并能明显改善活菌稳定性,充分保障产品货架期活菌数的质量要求;(3)本发明制备得到的活性保护组合物成分简单,适用性广,能广泛应用于各种益生菌粉剂产品。Compared with the prior art, the present invention has the following beneficial effects: (1) The present invention combines whole-fat or skimmed milk powder and sodium citrate in a certain proportion, and controls the particle size of the composition within a certain range through a granulation process. The prepared active protective composition can effectively ensure the water activity, and has good powder bag packaging process compliance, and can significantly improve the survival rate of live bacteria passing through the lower digestive tract of the human body; (2) The active protective composition prepared by the present invention is combined with probiotics and other food ingredients to produce a probiotic powder product, whose water activity value is less than 0.15, and can significantly improve the stability of live bacteria, fully ensuring the quality requirements of the number of live bacteria during the shelf life of the product; (3) The active protective composition prepared by the present invention has simple ingredients and wide applicability, and can be widely used in various probiotic powder products.

具体实施方式Detailed ways

对本发明实施例中的技术方案作进一步清晰地描述,所描述的实施例只是本发明的一部分,用于解释本发明,但不用于限定本发明,因此本领域其他技术人员在没有创造性劳动的前提下所获得的其他实施例,均属于本发明的保护范围。The technical solutions in the embodiments of the present invention are further clearly described. The described embodiments are only a part of the present invention and are used to explain the present invention but not to limit the present invention. Therefore, other embodiments obtained by other technicians in the field without creative work all belong to the protection scope of the present invention.

本发明实施例所用的原料均来源于市购。The raw materials used in the embodiments of the present invention are all commercially available.

实施例1Example 1

在添加相同填充剂(该实施例中选择抗性糊精)的基础上,以全脂乳粉或脱脂乳粉以及柠檬酸钠为组分,并调节各成分的使用量,形成活性保护组合物;并测试其在pH3.0的盐酸溶液中酸碱度,以评估不同配方样品的缓冲能力。为满足该组合物未来在益生菌粉剂产品中的应用,同时加入水分活度以及活菌总数作为筛选项目。On the basis of adding the same filler (resistant dextrin is selected in this example), whole milk powder or skim milk powder and sodium citrate are used as components, and the amount of each component is adjusted to form an active protection composition; and its pH in a hydrochloric acid solution of pH 3.0 is tested to evaluate the buffering capacity of different formula samples. In order to meet the future application of the composition in probiotic powder products, water activity and total viable bacteria count are added as screening items.

制备方法:Preparation:

(1)称量、备料:按配方量称量全脂乳粉或脱脂乳粉、柠檬酸钠、抗性糊精和益生菌粉,具体配方见表1-1;(1) Weighing and preparing materials: weigh whole milk powder or skim milk powder, sodium citrate, resistant dextrin and probiotic powder according to the formula. The specific formula is shown in Table 1-1;

(2)混合、造粒:将全脂乳粉或脱脂乳粉、柠檬酸钠和抗性糊精置于混合机中,混合均匀后,置于造粒机中,喷浆造粒,并烘干至水分<0.5%,得到粒度符合100%过10目筛,大于90%过40目筛,小于60%过200目筛的活性保护组合物;(2) Mixing and granulation: whole milk powder or skim milk powder, sodium citrate and resistant dextrin are placed in a mixer, mixed evenly, placed in a granulator, spray granulated, and dried to a moisture content of less than 0.5% to obtain an active protective composition having a particle size of 100% passing through a 10-mesh sieve, more than 90% passing through a 40-mesh sieve, and less than 60% passing through a 200-mesh sieve;

(3)总混:将益生菌粉(动物双歧杆菌乳亚种HN019:鼠李糖乳酪杆菌GG:鼠李糖乳酪杆菌HN001=1:1:1)和上述组合物一起投入混合机中,混合均匀后出料,得到益生菌粉剂。(3) Total mixing: Put the probiotic powder (Bifidobacterium animalis subsp. lactis HN019: Lactobacillus rhamnosus GG: Lactobacillus rhamnosus HN001=1:1:1) and the above composition into a mixer, mix well and then discharge to obtain a probiotic powder.

检测方法:Detection method:

酸处理前样品的pH值和活菌总数的具体操作如下:取样品1.0g溶于适量生理盐水(0.9%,99.0mL),制成样品溶液并测量其pH值;然后用GB4789.35检测益生菌总数。The specific operation of the pH value and total viable bacteria count of the sample before acid treatment is as follows: 1.0 g of the sample is dissolved in an appropriate amount of physiological saline (0.9%, 99.0 mL) to prepare a sample solution and measure its pH value; then the total probiotic count is detected using GB4789.35.

水分活度的检测可以参考GB5009.238-2016,食品安全国家标准食品水分活度的测定。The detection of water activity can refer to GB5009.238-2016, National Food Safety Standard Determination of Water Activity of Food.

酸处理以及样品的活菌总数的检测具体操作如下:取不同配比的样品25.0g溶于225mL的pH3.0盐酸溶液,37℃,摇床2h,然后用GB4789.35检测益生菌总数。检测结果如表1-2所示。The specific operation of acid treatment and detection of total viable bacteria of samples is as follows: 25.0g of samples with different proportions are dissolved in 225mL of pH 3.0 hydrochloric acid solution, shaken at 37℃ for 2h, and then the total number of probiotics is detected using GB4789.35. The test results are shown in Table 1-2.

表1-1全脂或脱脂乳粉与柠檬酸钠不同配比的样品配方Table 1-1 Sample formulas of different ratios of whole or skim milk powder and sodium citrate

表1-2全脂-或脱脂-乳粉与柠檬酸钠不同配比的样品配方检测结果Table 1-2 Test results of sample formulas with different ratios of whole-fat or skimmed milk powder and sodium citrate

选择标准:(1)为了保障益生菌生物活性,优选益生菌存活率大于80%的配方。(2)水分活度反映的是食品中水分的结合程度(游离程度),数值越高,结合程度越低,反之亦然。水分活度是食品保存性能的重要指标,水分活度对益生菌产品货架期菌活有重要影响。结合菌株的特异性、生产成本、加工工艺等方面考虑,一般认为含益生菌的粉剂产品其水分活度宜控制在低于0.20。并按照GB5009.238的要求,具体结果保留两位有效数字。因此为了满足益生菌粉剂产品的质量要求,优选水分活度低于0.20、酸处理存活率大于80%的配方。Selection criteria: (1) In order to ensure the biological activity of probiotics, formulas with a probiotic survival rate greater than 80% are preferred. (2) Water activity reflects the degree of water binding (free degree) in food. The higher the value, the lower the degree of binding, and vice versa. Water activity is an important indicator of food preservation performance, and water activity has an important impact on the shelf life of probiotic products. Considering the specificity of the strain, production cost, processing technology and other aspects, it is generally believed that the water activity of powder products containing probiotics should be controlled below 0.20. And in accordance with the requirements of GB5009.238, the specific results are retained to two significant figures. Therefore, in order to meet the quality requirements of probiotic powder products, formulas with a water activity of less than 0.20 and an acid treatment survival rate greater than 80% are preferred.

由上述结果可知,综合不同组合配方在pH3.0溶液下酸碱度的检测值及其活菌存活率,以及样品的水分活度,试验组1-6、试验组1-7、试验组1-8和试验组1-9均能满足筛选要求。From the above results, it can be seen that based on the pH detection values of different combination formulas in pH 3.0 solution and their viable bacterial survival rates, as well as the water activity of the samples, test groups 1-6, 1-7, 1-8 and 1-9 can all meet the screening requirements.

实施例2Example 2

基于实施例1的结果,本实施例对酸处理存活率大于90%的试验组1-7和试验组1-8所得的益生菌粉剂样品进行试验,验证两组在模拟人体标准胃液(Simulated GastricFluid,SGF)中的耐受性。Based on the results of Example 1, this example tests the probiotic powder samples obtained from test groups 1-7 and 1-8 with acid treatment survival rates greater than 90% to verify the tolerance of the two groups in simulated human standard gastric fluid (SGF).

具体操作如下:The specific operations are as follows:

(1)模拟人体标准胃液(SGF)的制备:分别称量NaCl 2.0g和胃蛋白酶(每毫克中含800-2500个活性单位)3.2g,加入浓HCl 7.0ml,并用蒸馏水定容至1000ml,混合均匀后调节pH值至3.0,静置2h后,过滤除菌后备用。(1) Preparation of simulated human standard gastric juice (SGF): weigh 2.0 g of NaCl and 3.2 g of pepsin (800-2500 active units per mg), add 7.0 ml of concentrated HCl, and make up to 1000 ml with distilled water. Mix well and adjust the pH to 3.0. Let stand for 2 h, filter and sterilize before use.

(2)先预热上述模拟胃液到37℃,稀释益生菌粉剂样品(10倍稀释,25g益生菌粉剂样品+225mlSGF),混匀后,37℃,摇床2h,然后按照GB 4789.35-2023检测益生菌总数。检测结果如表2所示。(2) Preheat the simulated gastric fluid to 37°C, dilute the probiotic powder sample (10-fold dilution, 25 g probiotic powder sample + 225 ml SGF), mix well, shake at 37°C for 2 hours, and then test the total number of probiotics according to GB 4789.35-2023. The test results are shown in Table 2.

表2全脂或脱脂乳粉与柠檬酸钠不同配比的样品模拟胃液耐受性结果Table 2 Simulated gastric juice tolerance results of samples with different ratios of whole or skim milk powder and sodium citrate

由上述结果可知,试验组1-7和试验组1-8在模拟人体胃液中有良好的耐受性,两组中益生菌活菌存活率均超过了80%。From the above results, it can be seen that test groups 1-7 and test groups 1-8 have good tolerance in simulated human gastric juice, and the survival rate of live probiotics in both groups exceeds 80%.

实施例3Example 3

基于实施例2的结果,本实施例进一步验证使用上述活性保护组合物以及益生菌粉,形成的试验组配方样品,在模拟下消化道条件下的耐受性。相对应地,设立不添加上述活性保护组合物的对比组配方样品。Based on the results of Example 2, this example further verifies the tolerability of the test group formula samples formed by using the above active protective composition and probiotic powder under simulated lower digestive tract conditions. Correspondingly, a control group formula sample without adding the above active protective composition is set up.

具体操作如下:The specific operations are as follows:

(1)试验组配方:抗性糊精(339mg)+赤藓糖醇(212mg)+麦芽糖醇(212mg)+益生菌粉(132mg,鼠李糖乳酪杆菌GG:动物双歧杆菌乳亚种BL-04:动物双歧杆菌乳亚种Bi-07:嗜酸乳杆菌NCFM=3:1:1:1)+全脂乳粉(100mg)+柠檬酸钠(5mg);(1) Test group formula: resistant dextrin (339 mg) + erythritol (212 mg) + maltitol (212 mg) + probiotic powder (132 mg, Lactobacillus rhamnosus GG: Bifidobacterium animalis subsp. lactis BL-04: Bifidobacterium animalis subsp. lactis Bi-07: Lactobacillus acidophilus NCFM = 3:1:1:1) + whole milk powder (100 mg) + sodium citrate (5 mg);

(2)对比组配方:抗性糊精(388mg)+赤藓糖醇(240mg)+麦芽糖醇(240mg)+益生菌粉(132mg,鼠李糖乳酪杆菌GG:动物双歧杆菌乳亚种BL-04:动物双歧杆菌乳亚种Bi-07:嗜酸乳杆菌NCFM=3:1:1:1);(2) Comparative group formula: resistant dextrin (388 mg) + erythritol (240 mg) + maltitol (240 mg) + probiotic powder (132 mg, Lactobacillus rhamnosus GG: Bifidobacterium animalis subsp. lactis BL-04: Bifidobacterium animalis subsp. lactis Bi-07: Lactobacillus acidophilus NCFM = 3:1:1:1);

(3)模拟人体标准胃液(SGF)的制备:分别称量NaCl 2.0g和胃蛋白酶(每毫克中含800-2500个活性单位)3.2g,加入浓HCl 7.0mL,并用蒸馏水定容至1000mL,混合均匀后调节pH值至3.0,静置2h后,过滤除菌后备用;(3) Preparation of simulated human standard gastric juice (SGF): weigh 2.0 g of NaCl and 3.2 g of pepsin (800-2500 active units per mg), add 7.0 mL of concentrated HCl, and dilute to 1000 mL with distilled water. After mixing well, adjust the pH value to 3.0, let stand for 2 h, filter and sterilize, and set aside.

(4)含0.3%胆盐的模拟肠液的制备:称量6.8g磷酸二氢钾,用适量dH2O溶解,加77mL 0.2mol/L NaOH,定容至1000mL,灭菌,加入10.0g胰酶和3.0g胆盐,混匀,用HCl或NaOH溶液调pH至6.8,静置,过滤除菌后备用。(4) Preparation of simulated intestinal fluid containing 0.3% bile salts: Weigh 6.8 g potassium dihydrogen phosphate, dissolve it with an appropriate amount of dH2O , add 77 mL 0.2 mol/L NaOH, make up to 1000 mL, sterilize, add 10.0 g pancreatic enzyme and 3.0 g bile salts, mix well, adjust the pH to 6.8 with HCl or NaOH solution, let stand, filter and sterilize for later use.

(5)在无菌条件下,分别称取上述试验组和对比组样品各25g到无菌容器中,分别加225mL模拟胃液(SGF),均质1~2min使样品溶解,37℃厌氧培养2小时;(5) Under sterile conditions, weigh 25 g of the test group and control group samples respectively into sterile containers, add 225 mL of simulated gastric fluid (SGF) respectively, homogenize for 1 to 2 min to dissolve the samples, and incubate anaerobically at 37 °C for 2 h;

(6)分别上述取经过2h模拟胃液处理的样液25mL,加入225mL含0.3%胆盐的模拟肠液,混匀,37℃培养2h后,参照GB 4789.35测乳酸菌总数。检测结果,如表3所示。(6) Take 25 mL of the sample solution treated with simulated gastric juice for 2 hours, add 225 mL of simulated intestinal juice containing 0.3% bile salt, mix well, incubate at 37°C for 2 hours, and measure the total number of lactic acid bacteria according to GB 4789.35. The test results are shown in Table 3.

表3不同配方样品在模拟人体下消化道条件的耐受性检测结果Table 3 Tolerance test results of different formula samples under simulated human lower digestive tract conditions

由上述结果可知,与未添加活性保护组合物的对比组相比较,添加了活性保护组合物的试验组在模拟人体下消化道条件的耐受性得到了显著提高,能更好地帮助益生菌抵御人体内胃酸、胆盐和肠液等因素的干扰,提高活菌通过人体下消化道的存活率。From the above results, it can be seen that compared with the control group without adding the active protective composition, the test group with added active protective composition has significantly improved tolerance in conditions simulating the lower digestive tract of the human body, which can better help probiotics resist interference from factors such as gastric acid, bile salts and intestinal fluid in the human body, and improve the survival rate of live bacteria through the lower digestive tract of the human body.

实施例4Example 4

为了满足益生菌粉剂生产工艺对物料流动性的要求,本实施例考察上述活性保护组合物,在造粒后不同颗粒度下,袋包工艺的顺应性。In order to meet the requirements of the probiotic powder production process on material fluidity, this example examines the compliance of the above-mentioned active protective composition with the bag packaging process at different particle sizes after granulation.

制备方法:Preparation:

(1)称量、备料:分别称量860mg抗性糊精、益生菌粉35mg(副干酪乳酪杆菌LPB27:植物乳植杆菌6595=2:1)、100mg全脂乳粉和5mg柠檬酸钠;(1) Weighing and preparing materials: Weigh 860 mg of resistant dextrin, 35 mg of probiotic powder (Lactobacillus paracasei LPB27: Lactobacillus plantarum 6595 = 2:1), 100 mg of whole milk powder and 5 mg of sodium citrate respectively;

(2)混合、造粒:将全脂乳粉、柠檬酸钠和抗性糊精置于混合机中,调节喷浆条件,控制粉末造粒的颗粒度大小,得到活性保护组合物;(2) Mixing and granulating: placing whole milk powder, sodium citrate and resistant dextrin in a mixer, adjusting spraying conditions, controlling the particle size of powder granulation, and obtaining an active protective composition;

(3)总混:将益生菌粉和活性保护组合物一起投入混合机中,混合均匀后出料,得到益生菌粉剂;(3) Total mixing: putting the probiotic powder and the active protection composition into a mixer, mixing them evenly and then discharging the mixture to obtain a probiotic powder;

(4)分装:调整好设备,净重量控制在平均每袋1.0g,每袋装量差异±6.5%,每30分钟检查一次装量差异和外观。(4) Packaging: Adjust the equipment to control the net weight to an average of 1.0 g per bag, with a packing difference of ±6.5% per bag. Check the packing difference and appearance every 30 minutes.

上述配方中粉剂在同一生产环境、同一造粒设备、同一混合设备、同一袋包机的情况下,更换不同粒度的活性保护组合物,考察制备粉剂过程的密封性和装量差异,颗粒度及检测结果如表4所示。In the above formula, the powders were prepared in the same production environment, the same granulation equipment, the same mixing equipment, and the same bagging machine. The active protective compositions of different particle sizes were replaced to investigate the sealing and loading differences in the powder preparation process. The particle size and test results are shown in Table 4.

表4含不同粒度活性保护组合物的粉剂工艺顺应性及口感评分Table 4 Process compliance and taste scores of powders containing active protective compositions of different particle sizes

注:(1)口腔溶解评分:0-10分,粉末抱团黏牙-粉末溶解无渣感;(2)粗细度评分指标:0-10分,颗粒度高-细腻度高。(3)选择标准:在兼顾生产工艺可行,优选口腔溶解评分/粗细度评分大于7/6的组合。Note: (1) Oral dissolution score: 0-10 points, powder clumping and sticking to teeth - powder dissolving without residue feeling; (2) Coarseness score index: 0-10 points, high particle size - high fineness. (3) Selection criteria: Taking into account the feasibility of production process, the combination of oral dissolution score/coarseness score greater than 7/6 is preferred.

由上述结果可知,采用100%过10目,大于90%过40目,小于60%过200目的活性保护组合物应用于实际生产具备良好的工艺顺应性,并实现口腔溶解快、口感细腻的要求。From the above results, it can be seen that the active protective composition with 100% passing 10 mesh, more than 90% passing 40 mesh, and less than 60% passing 200 mesh has good process compliance when applied to actual production, and achieves the requirements of fast oral dissolution and delicate taste.

实施例5Example 5

本实施例考察不同益生菌粉含量的粉剂的工艺顺应性和活菌数存活稳定性。This example investigates the process compliance and viable bacteria survival stability of powders with different probiotic powder contents.

分析不同的粉剂的工艺顺应性、货架期稳定性、以及在酸处理后的酸碱度及其活菌存活率,以评估该活性保护组合物在不同活菌数含量的益生菌粉剂产品中的适用性。The process compliance, shelf life stability, pH value and viable bacteria survival rate of different powders were analyzed to evaluate the applicability of the active protection composition in probiotic powder products with different viable bacteria counts.

制备方法:Preparation:

(1)称量、备料:按配方量称量全脂乳粉、柠檬酸钠、抗性糊精和益生菌粉(副干酪乳杆菌Lpc-37:鼠李糖乳酪杆菌HN001:格氏乳杆菌Lg36:短双歧杆菌M-16V=1:1:1:4),具体配方见下表5-1;(2)混合、造粒:将全脂乳粉、柠檬酸钠和抗性糊精置于混合机中,混合均匀后,置于造粒机中,喷浆造粒,并烘干至水分<0.5%,得到粒度符合100%过10目筛,大于90%过40目筛,小于60%过200目筛的活性保护组合物;(1) Weighing and preparing materials: weigh whole milk powder, sodium citrate, resistant dextrin and probiotic powder (Lactobacillus paracasei Lpc-37: Lactobacillus rhamnosus HN001: Lactobacillus gasseri Lg36: Bifidobacterium breve M-16V=1:1:1:4) according to the formula. The specific formula is shown in Table 5-1 below; (2) Mixing and granulating: put whole milk powder, sodium citrate and resistant dextrin in a mixer, mix them evenly, put them in a granulator, spray granulate, and dry them until the moisture content is less than 0.5%, to obtain an active protective composition with a particle size of 100% passing through a 10-mesh sieve, more than 90% passing through a 40-mesh sieve, and less than 60% passing through a 200-mesh sieve;

(3)总混:将益生菌粉和活性保护组合物一起投入混合机中,混合均匀后出料,得到益生菌粉剂;(3) Total mixing: putting the probiotic powder and the active protection composition into a mixer, mixing them evenly and then discharging the mixture to obtain a probiotic powder;

(4)分装:调整好设备,净重量控制在平均每袋1.0g,每袋装量差异±6.5%,每30分钟检查一次装量差异和外观。(4) Packaging: Adjust the equipment to control the net weight to an average of 1.0 g per bag, with a packing difference of ±6.5% per bag. Check the packing difference and appearance every 30 minutes.

表5-1不同菌粉含量的粉剂配方组成Table 5-1 Powder formulation composition with different bacterial powder contents

试验组5-1Test group 5-1 试验组5-2Test group 5-2 试验组5-3Test group 5-3 抗性糊精Resistant dextrin 860mg860mg 860mg860mg 860mg860mg 益生菌粉Probiotic powder 18mg18mg 78mg78mg 146mg146mg 全脂乳粉Whole milk powder 100mg100mg 100mg100mg 100mg100mg 柠檬酸钠Sodium citrate 5mg5mg 5mg5mg 5mg5mg

上述益生菌粉剂在同一生产环境,同一混合设备,同一袋包机的情况下,更换不同含量的同一益生菌粉。The above-mentioned probiotic powder is replaced with the same probiotic powder of different contents under the same production environment, the same mixing equipment and the same bag packaging machine.

考察制备粉剂过程的工艺顺应性(如密封性、装量差异、回收率)及其水分活度,检测结果如表5-2所示。The process compliance of powder preparation (such as sealing, filling volume difference, recovery rate) and water activity were investigated. The test results are shown in Table 5-2.

表5-2不同含量益生菌粉的粉剂工艺顺应性结果Table 5-2 Powder process compliance results of probiotic powders with different contents

检测指标Detection Indicator 试验组5-1Test group 5-1 试验组5-2Test group 5-2 试验组5-3Test group 5-3 密封性Sealing 真空抽检无漏气Vacuum inspection without leakage 真空抽检无漏气Vacuum inspection without leakage 真空抽检无漏气Vacuum inspection without leakage 装量差异Difference in filling volume 装量稳定Stable loading 装量稳定Stable loading 装量稳定Stable loading 回收率Recovery rate 99.78%99.78% 99.25%99.25% 99.65%99.65% 水分活度Water activity 0.050.05 0.060.06 0.080.08

由上述结果可知,本发明活性保护组合物(如抗性糊精、全脂乳粉、柠檬酸钠)应用于不同益生菌粉添加量的配方中均有良好的工艺顺应性,并控制水分活度不大于0.1。From the above results, it can be seen that the active protection composition of the present invention (such as resistant dextrin, whole milk powder, sodium citrate) has good process compliance when applied to formulas with different probiotic powder addition amounts, and the water activity is controlled to be no more than 0.1.

对制备得到的粉剂中的益生菌含量及其加速3个月稳定性考察后其水分活度进行检测,试验结果如表5-3所示。The probiotic content in the prepared powder and its water activity after accelerated 3-month stability study were tested. The test results are shown in Table 5-3.

表5-3不同含量益生菌粉的粉剂稳定性考察结果Table 5-3 Results of stability test of probiotic powder with different contents

检测指标Detection Indicator 试验组5-1Test group 5-1 试验组5-2Test group 5-2 试验组5-3Test group 5-3 理论益生菌结果,亿CFU/gTheoretical probiotic results, 100 million CFU/g 7575 320320 600600 袋包后样品益生菌检测结果,亿CFU/gProbiotic test results of samples after bagging, 100 million CFU/g 9595 450450 730730 加速(37℃,75%)3个月后益生菌总数,亿CFU/gAccelerated (37℃, 75%) probiotic count after 3 months, 100 million CFU/g 7474 350350 620620 加速(37℃,75%)3个月后水分活度Accelerated (37℃, 75%) water activity after 3 months 0.080.08 0.090.09 0.110.11

注:评判标准符合活菌一级标的团标要求。Note: The evaluation criteria are in line with the group standard requirements for the first-level live bacteria standard.

由上述结果可知,活性保护组合物(如抗性糊精、全脂乳粉、柠檬酸钠)应用于不同益生菌粉添加量的配方中均有良好的活菌稳定性。From the above results, it can be seen that the active protection composition (such as resistant dextrin, whole milk powder, sodium citrate) applied to the formula with different probiotic powder addition amounts has good live bacteria stability.

对制备得到的粉剂,使用模拟胃酸溶液进行处理,并检测其活菌总数及其存活率。试验结果如表5-4所示。The prepared powder was treated with simulated gastric acid solution, and the total number of viable bacteria and its survival rate were tested. The test results are shown in Table 5-4.

表5-4不同含量益生菌粉的粉剂对酸处理的耐受性分析Table 5-4 Analysis of the tolerance of probiotic powders with different contents to acid treatment

检测指标Detection Indicator 试验组5-1Test group 5-1 试验组5-2Test group 5-2 试验组5-3Test group 5-3 样品益生菌检测结果,亿CFU/gSample probiotic test results, 100 million CFU/g 9595 450450 730730 酸处理后益生菌总数,亿CFU/gTotal number of probiotics after acid treatment, 100 million CFU/g 8888 410410 660660 活菌存活率Live bacteria survival rate 92.6%92.6% 91.1%91.1% 90.4%90.4%

由上述结果可知,活性保护组合物(如抗性糊精、全脂乳粉、柠檬酸钠)应用于不同益生菌粉添加量的粉剂对于酸溶剂均有有良好的缓存能力,能更好保护益生菌以抵御胃酸的破坏。From the above results, it can be seen that the active protective composition (such as resistant dextrin, whole milk powder, sodium citrate) applied to powders with different probiotic powder addition amounts has a good caching capacity for acid solvents and can better protect probiotics from damage by gastric acid.

实施例6Example 6

使用全脂乳粉和柠檬酸钠,搭配糖醇类、低聚糖类、膳食纤维类、果汁粉类等益生菌粉剂产品常用的食品用原辅料成分,以及益生菌粉,形成不同的配方粉剂样品。从而对比分析不同的配方粉剂样品在模拟胃液和肠液处理后的活菌存活率,以及评估该活性保护组合物在不同益生菌粉剂产品中的适用性。Whole milk powder and sodium citrate were used in combination with sugar alcohols, oligosaccharides, dietary fiber, fruit juice powder and other food raw materials and auxiliary ingredients commonly used in probiotic powder products, as well as probiotic powder to form different formula powder samples. The survival rates of live bacteria of different formula powder samples after treatment with simulated gastric juice and intestinal juice were compared and analyzed, and the applicability of the active protection composition in different probiotic powder products was evaluated.

6.1:添加膳食纤维类:6.1: Add dietary fiber:

试验组6.1.1抗性糊精(965mg)+益生菌粉(35mg);Experimental group 6.1.1 resistant dextrin (965 mg) + probiotic powder (35 mg);

试验组6.1.2抗性糊精(860mg)+益生菌粉(35mg)+全脂乳粉(100mg)+柠檬酸钠(5mg);Test group 6.1.2: resistant dextrin (860 mg) + probiotic powder (35 mg) + whole milk powder (100 mg) + sodium citrate (5 mg);

6.2:添加膳食纤维类+糖醇类:6.2: Add dietary fiber + sugar alcohols:

试验组6.2.1抗性糊精(431mg)+赤藓糖醇(267mg)+麦芽糖醇(267mg)+益生菌粉(35mg);Experimental group 6.2.1: resistant dextrin (431 mg) + erythritol (267 mg) + maltitol (267 mg) + probiotic powder (35 mg);

试验组6.2.2抗性糊精(380mg)+赤藓糖醇(240mg)+麦芽糖醇(240mg)+益生菌粉(35mg)+全脂乳粉(100mg)+柠檬酸钠(5mg);Experimental group 6.2.2: resistant dextrin (380 mg) + erythritol (240 mg) + maltitol (240 mg) + probiotic powder (35 mg) + whole milk powder (100 mg) + sodium citrate (5 mg);

6.3:添加膳食纤维类+糖醇类+低聚糖类6.3: Add dietary fiber + sugar alcohol + oligosaccharides

试验组6.3.1抗性糊精(385mg)+赤藓糖醇(240mg)+麦芽糖醇(240mg)+低聚果糖(100mg)+益生菌粉(35mg);Experimental group 6.3.1: resistant dextrin (385 mg) + erythritol (240 mg) + maltitol (240 mg) + oligofructose (100 mg) + probiotic powder (35 mg);

试验组6.3.2抗性糊精(340mg)+赤藓糖醇(210mg)+麦芽糖醇(210mg)+低聚果糖(100mg)+益生菌粉(35mg)+全脂乳粉(100mg)+柠檬酸钠(5mg);Experimental group 6.3.2: resistant dextrin (340 mg) + erythritol (210 mg) + maltitol (210 mg) + oligofructose (100 mg) + probiotic powder (35 mg) + whole milk powder (100 mg) + sodium citrate (5 mg);

6.4:添加膳食纤维类+糖醇类+低聚糖类+果汁粉类:6.4: Add dietary fiber + sugar alcohol + oligosaccharides + fruit juice powder:

试验组6.4.1抗性糊精(340mg)+赤藓糖醇(212.5mg)+麦芽糖醇(212.5mg)+低聚果糖(100mg)+蔓越莓果汁粉(100mg)+益生菌粉(35mg);Experimental group 6.4.1: resistant dextrin (340 mg) + erythritol (212.5 mg) + maltitol (212.5 mg) + oligofructose (100 mg) + cranberry juice powder (100 mg) + probiotic powder (35 mg);

试验组6.4.2抗性糊精(294mg)+赤藓糖醇(183mg)+低聚果糖(183mg)+蔓越莓果汁粉(100mg)+益生菌粉(35mg)+全脂乳粉(100mg)+柠檬酸钠(5mg)。Experimental group 6.4.2 Resistant dextrin (294 mg) + erythritol (183 mg) + oligofructose (183 mg) + cranberry juice powder (100 mg) + probiotic powder (35 mg) + whole milk powder (100 mg) + sodium citrate (5 mg).

上述益生菌粉的组成比例为:鼠李糖乳酪杆菌Lr32 28.7%;动物双歧杆菌乳亚种BL-047.3%;植物乳植杆菌Lp115 7.3%;鼠李糖乳酪杆菌GG 9.6%;唾液链球菌嗜热亚种St215.9%;干酪乳杆菌Lc-11 7.8%;副干酪乳杆菌Lpc-37 2.9%;鼠李糖乳酪杆菌HN0012.0%;动物双歧杆菌乳亚种HN019 2.3%;格氏乳杆菌Lg36 2.3%;德氏乳杆菌保加利亚亚种Lb-87 3.7%;罗伊氏粘液乳杆菌1E1 3.7%;长双歧杆菌婴儿亚种M-63 3.4%;短双歧杆菌M-16V 7.3%和长双歧杆菌长亚种BB536 5.7%。The composition ratio of the above probiotic powder is: Lactobacillus rhamnosus Lr32 28.7%; Bifidobacterium animalis lactis subsp. BL-04 7.3%; Lactobacillus plantarum Lp115 7.3%; Lactobacillus rhamnosus GG 9.6%; Streptococcus salivarius thermophilic subsp. St21 5.9%; Lactobacillus casei Lc-11 7.8%; Lactobacillus paracasei Lpc-37 2.9%; Lactobacillus rhamnosus HN001 2.0%; Bifidobacterium animalis lactis subsp. HN019 2.3%; Lactobacillus gasseri Lg36 2.3%; Lactobacillus delbrueckii subsp. bulgaricus Lb-87 3.7%; Lactobacillus reuteri mucin 1E1 3.7%; Bifidobacterium longum infantis subsp. M-63 3.4%; Bifidobacterium breve M-16V 7.3% and Bifidobacterium longum subsp. BB536 5.7%.

益生菌粉剂的制备方法:Preparation method of probiotic powder:

(1)称量、备料、混合:按配方量称量,将上述各组中除益生菌粉外的其他原料分别置于混合机中,混合至物料色泽质地均匀后,得到混合物;(1) Weighing, preparing materials, and mixing: Weighing according to the formula amount, placing the other raw materials in each group except the probiotic powder in a mixer, and mixing until the materials have a uniform color and texture to obtain a mixture;

(2)造粒:将步骤(1)中得到的混合物置于造粒机中,喷浆造粒,并烘干至水分<0.5%,水分活度<0.1,得到粒度符合100%过10目筛,大于90%过40目筛,小于60%过200目筛的活性保护组合物;(2) Granulation: placing the mixture obtained in step (1) in a granulator, spraying granulation, and drying until the moisture content is less than 0.5% and the water activity is less than 0.1, to obtain an active protective composition having a particle size of 100% passing through a 10-mesh sieve, more than 90% passing through a 40-mesh sieve, and less than 60% passing through a 200-mesh sieve;

(3)总混:将益生菌粉和上述活性保护组合物一起投入混合机中,混合均匀后出料,得到益生菌粉剂;(3) Total mixing: putting the probiotic powder and the above-mentioned active protective composition into a mixer, mixing them evenly and then discharging the mixture to obtain a probiotic powder;

(4)分装:调整好设备,净重量控制在平均每袋1.0g,每袋装量差异±6.5%,每30分钟检查一次装量差异和外观。(4) Packaging: Adjust the equipment to control the net weight to an average of 1.0 g per bag, with a packing difference of ±6.5% per bag. Check the packing difference and appearance every 30 minutes.

考察不同的配方粉剂样品在模拟胃酸和肠液处理后的活菌存活率,检测结果如表6所示。The viable bacterial survival rates of powder samples with different formulas after treatment with simulated gastric acid and intestinal fluid were investigated. The test results are shown in Table 6.

表6不同的配方粉剂样品在酸处理后的pH值及活菌存活率检测结果Table 6 pH value and viable bacteria survival rate test results of different formula powder samples after acid treatment

由上述结果可知,本发明活性保护组合物,搭配糖醇类、低聚糖类、膳食纤维类、果汁粉类等益生菌粉剂产品常用的食品用原辅料成分,具有广泛适应性。同时,通过对比数据可知,本发明活性保护组合物能有效提升整体配方对下消化道的耐受性,从而显著提高益生菌粉剂中活菌成分通过胃肠道的存活率。From the above results, it can be seen that the active protective composition of the present invention, combined with sugar alcohols, oligosaccharides, dietary fibers, fruit juice powders and other food raw materials and auxiliary materials commonly used in probiotic powder products, has wide adaptability. At the same time, through comparative data, it can be seen that the active protective composition of the present invention can effectively improve the tolerance of the overall formula to the lower digestive tract, thereby significantly improving the survival rate of the live bacteria components in the probiotic powder through the gastrointestinal tract.

上述详细说明是针对本发明其中之一可行实施例的具体说明,该实施例并非用以限制本发明的专利范围,凡未脱离本发明所为的等效实施或变更,均应包含于本发明技术方案的范围内。The above detailed description is a specific description of one feasible embodiment of the present invention. The embodiment is not intended to limit the patent scope of the present invention. Any equivalent implementation or modification that does not deviate from the present invention should be included in the scope of the technical solution of the present invention.

Claims (10)

1. A method of maintaining the activity of a probiotic, the method comprising adding an active protective composition to a probiotic powder; the active protection composition comprises milk powder and sodium citrate, wherein the mass ratio of the milk powder to the sodium citrate is 10-25:1.
2. The method of claim 1, wherein the active protective composition is prepared by mixing, granulating, and sieving the milk powder and sodium citrate; the sieving is specifically as follows: the active protective composition is screened through a sieve with 180-220 meshes, the content of undersize is less than 60% of the total amount, the undersize is screened through a sieve with 35-45 meshes, the content of undersize is more than 90% of the total amount, the undersize is screened through a sieve with 10-20 meshes, and the content of undersize is equal to 100%.
3. An active protection composition for maintaining the activity of probiotics, which is characterized by comprising milk powder and sodium citrate, wherein the mass ratio of the milk powder to the sodium citrate is 10-25:1.
4. An active protective composition according to claim 3, wherein the mass ratio of milk powder to sodium citrate is 15-25:1.
5. The active protective composition according to claim 3, further comprising a filler, wherein the mass ratio of filler to milk powder to sodium citrate is 150-180:15-25:1.
6. The active protective composition according to claim 5, wherein the filler is selected from at least one of dietary fiber selected from at least one of resistant dextrin and maltodextrin, sugar alcohol selected from at least one of erythritol and maltitol, oligosaccharide selected from at least one of fructo-oligosaccharides and galacto-oligosaccharides.
7. The active protective composition of claim 5, wherein the filler comprises resistant dextrin, erythritol and maltitol in a mass ratio of 3-5:2-3:2-3.
8. The active protective composition according to any one of claims 3 to 7, wherein the active protective composition is screened through a 180-220 mesh screen, the undersize content is less than 60% of the total amount, screened through a 35-45 mesh screen, the undersize content is greater than 90% of the total amount, screened through a 10-20 mesh screen, and the undersize content is equal to 100%.
9. A high activity probiotic powder comprising the active protective composition of any one of claims 3-7.
10. The probiotic powder according to claim 9, characterized in that the mass ratio of probiotic powder to active protective composition in the probiotic powder is 80-100:1-15.
CN202410415297.1A 2024-04-08 2024-04-08 A method for maintaining probiotic activity and active protection composition Pending CN118203116A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202410415297.1A CN118203116A (en) 2024-04-08 2024-04-08 A method for maintaining probiotic activity and active protection composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202410415297.1A CN118203116A (en) 2024-04-08 2024-04-08 A method for maintaining probiotic activity and active protection composition

Publications (1)

Publication Number Publication Date
CN118203116A true CN118203116A (en) 2024-06-18

Family

ID=91456842

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202410415297.1A Pending CN118203116A (en) 2024-04-08 2024-04-08 A method for maintaining probiotic activity and active protection composition

Country Status (1)

Country Link
CN (1) CN118203116A (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001015714A1 (en) * 1999-08-26 2001-03-08 Zlotkin Stanley H Composition comprising micronutrients in combination with prebiotics, probiotics, and/or synbiotics
KR20020069862A (en) * 2001-02-28 2002-09-05 정명준 Manufacturing method of Protein- coated Lactic acid bacteria powder
CN1545936A (en) * 2003-12-01 2004-11-17 上海交大昂立股份有限公司 Edible combination containing active Lactobacillus paracasei and preparation method thereof
CN1766085A (en) * 2005-09-15 2006-05-03 中国科学院植物研究所 Vacuum freeze-dried product of yeast antagonistic bacteria and preparation method thereof
CN102031248A (en) * 2010-11-05 2011-04-27 钟春燕 Microbial live bacterium agent, preparation method and application thereof
US20180221422A1 (en) * 2015-07-29 2018-08-09 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
CN108783462A (en) * 2018-07-02 2018-11-13 哈尔滨美华生物技术股份有限公司 A kind of industrial process of beneficial bacteria of intestinal tract preparation
WO2020004933A1 (en) * 2018-06-26 2020-01-02 씨제이제일제당 (주) Composition for cryoprotection of lactic acid bacteria comprising citrate
CN111066888A (en) * 2019-12-30 2020-04-28 苏州良品优选科技股份有限公司 Probiotic powder
CN114259057A (en) * 2021-12-28 2022-04-01 汤臣倍健股份有限公司 Auxiliary material composition and probiotic powder thereof

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001015714A1 (en) * 1999-08-26 2001-03-08 Zlotkin Stanley H Composition comprising micronutrients in combination with prebiotics, probiotics, and/or synbiotics
KR20020069862A (en) * 2001-02-28 2002-09-05 정명준 Manufacturing method of Protein- coated Lactic acid bacteria powder
CN1545936A (en) * 2003-12-01 2004-11-17 上海交大昂立股份有限公司 Edible combination containing active Lactobacillus paracasei and preparation method thereof
CN1766085A (en) * 2005-09-15 2006-05-03 中国科学院植物研究所 Vacuum freeze-dried product of yeast antagonistic bacteria and preparation method thereof
CN102031248A (en) * 2010-11-05 2011-04-27 钟春燕 Microbial live bacterium agent, preparation method and application thereof
US20180221422A1 (en) * 2015-07-29 2018-08-09 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
WO2020004933A1 (en) * 2018-06-26 2020-01-02 씨제이제일제당 (주) Composition for cryoprotection of lactic acid bacteria comprising citrate
CN108783462A (en) * 2018-07-02 2018-11-13 哈尔滨美华生物技术股份有限公司 A kind of industrial process of beneficial bacteria of intestinal tract preparation
CN111066888A (en) * 2019-12-30 2020-04-28 苏州良品优选科技股份有限公司 Probiotic powder
CN114259057A (en) * 2021-12-28 2022-04-01 汤臣倍健股份有限公司 Auxiliary material composition and probiotic powder thereof

Similar Documents

Publication Publication Date Title
Gul Microencapsulation of Lactobacillus casei Shirota by spray drying using different combinations of wall materials and application for probiotic dairy dessert
Karimi et al. Viability of probiotic microorganisms in cheese during production and storage: a review
US7229818B2 (en) Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
US9579353B2 (en) Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
Millette et al. Gastrointestinal survival of bacteria in commercial probiotic products
CN111011867B (en) Probiotic embedded particle and preparation method thereof
Piatek et al. The viability and intestinal epithelial cell adhesion of probiotic strain combination-in vitro study
RU2560425C2 (en) Stabiliser of colour in bacterial composition
US20090214647A1 (en) Compositions For Enternal Application Of Microorganisms
CN102595938A (en) Heat resistant probiotic compositions and healthy food comprising them
US20170165303A1 (en) Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
EP2228067B1 (en) Probiotic compound and use of same
Nguyen et al. Evaluating the cryoprotective encapsulation of the lactic acid bacteria in simulated gastrointestinal conditions
Sarkar Approaches for enhancing the viability of probiotics: a review
Frakolaki et al. Effect of various encapsulating agents on the beads' morphology and the viability of cells during BB-12 encapsulation through extrusion
US20240268439A1 (en) Preparation method for diet-reducing capsule containing multi-nutrient microspheres and resulting product
CN109156686A (en) A method of the raising fermented juice storage period probiotic active based on microencapsulation
Jayalalitha et al. In vitro assessment of microencapsulated probiotic beads.
CN114259057B (en) Auxiliary material composition and probiotic powder thereof
CN111000247B (en) Preparation method of composite probiotic powder
CN115251393B (en) Probiotic microcapsule for improving intestinal flora and preparation method thereof
CN112890203A (en) Additive for maintaining activity of probiotics, composite probiotics and preparation method
Lai et al. Microencapsulation of Bifidobacterium lactis Bi-07 with galactooligosaccharides using co-extrusion technique
JP4135505B2 (en) Food for promoting colonization and growth of useful intestinal bacteria
CN118203116A (en) A method for maintaining probiotic activity and active protection composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination